Premortem diagnosis of sporadic creutzfeldt-jakob disease aided by positron-emission tomography imaging

American Journal of Neuroradiology

Volumn 32, Issue 1, 2011, Pages

  Zhang, W J ^a   Westover, M B ^a   Keary, C J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NEURON SPECIFIC ENOLASE; PROTEIN 14 3 3;

AGED; AKINETIC MUTISM; APRAXIA; ATAXIA; ATTENTION DISTURBANCE; CASE REPORT; COGNITIVE DEFECT; CREUTZFELDT JAKOB DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISORIENTATION; DRUG MEGADOSE; DYSARTHRIA; DYSPHAGIA; ELECTROENCEPHALOGRAM; FALLING; FEMALE; HALLUCINATION; HUMAN; IMAGE ANALYSIS; LETTER; MEMORY DISORDER; PARANOIA; POSITRON EMISSION TOMOGRAPHY; SINUS NODE;

BRAIN; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; POSTMORTEM CHANGES;

EID: 78651483733     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2292     Document Type: Letter

References (4)

1. Geschwind MD, Shu H, Haman A, et al. Rapidly progressive dementia. Ann Neurol 2008;64:97-108
2. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weightedMRIabnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63:443-49
3. Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2003;60:813-16
4. Henkel K, Zerr I, Hertel A, et al. Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol 2002;249:699-705